Studies on Haemophilus pertussis. IX. On the immunochemical properties of the toxin of H. pertussis.

No abstract is available for this paper.

• Publication year

  1957

• Venue

  Japanese Journal of Microbiology

• Publication date

  1957-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/J.1348-0421.1957.TB00036.XPMID 13562970
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Studies on antigenic substances of Hemophilus pertussis in phase I

  1954cited by this paper
• Protective antigen of haemophilus pertussis.

  1954cited by this paper
• PROTECTIVE ANTIGEN OF HÆMOPHILUS PERTUSSIS

  1954cited by this paper
• Studies on Haemophillus pertussis

  1953cited by this paper
• The separation of a protective antigen from a toxin-producing strain of Hemophilus pertussis.

  1950cited by this paper
• Studies on the antigenicity of toxic extracts of Hemophilus pertussis.

  1949cited by this paper
• Haemagglutinins of the Haemophilus group.

  1947cited by this paper
• Hæmagglutinins of the Hæmophilus Group

  1947cited by this paper
• Mouse Protection Tests in the Study of Pertussis Vaccine: A Comparative Series Using the Intracerebral Route for Challenge.

  1947cited by this paper
• Erythrophagocytosis and Hemosiderosis in the Liver and Spleen in Sickle Cell Disease.

  1943cited by this paper
• The production of pertussis antitxin in rabbits and the neutralisation of pertussis, parapertussis and bronchiseptica toxins

  1940cited by this paper
• The preparation of the toxin of H. pertussis: Its properties and relation to immunity

  1937cited by this paper

• Epithelial Anion Transporter Pendrin Contributes to Inflammatory Lung Pathology in Mouse Models of Bordetella pertussis Infection

  2014cites this paper
• Immunization with the Recombinant Cholera Toxin B Fused to Fimbria 2 Protein Protects against Bordetella pertussis Infection

  2014cites this paper
• In vivo phosphorylation dynamics of the Bordetella pertussis virulence‐controlling response regulator BvgA

  2013cites this paper
• Bordetella pertussis Infection Exacerbates Influenza Virus Infection through Pertussis Toxin-Mediated Suppression of Innate Immunity

  2011cites this paper
• Laboratory Adaptation of Bordetella pertussis Is Associated with the Loss of Type Three Secretion System Functionality

  2011cites this paper
• FHA-Mediated Cell-Substrate and Cell-Cell Adhesions Are Critical for Bordetella pertussis Biofilm Formation on Abiotic Surfaces and in the Mouse Nose and the Trachea

  2011cites this paper
• Variability in the lipooligosaccharide structure and endotoxicity among Bordetella pertussis strains.

  2010cites this paper
• Synergic Effect of Genotype Changes in Pertussis Toxin and Pertactin on Adaptation to an Acellular Pertussis Vaccine in the Murine Intranasal Challenge Model

  2010cites this paper
• Studies on the Chemical and Immunological Structure of Bordetella Pertussis

  2009cites this paper
• Identification of a Novel Lipopolysaccharide Core Biosynthesis Gene Cluster in Bordetella pertussis, and Influence of Core Structure and Lipid A Glucosamine Substitution on Endotoxic Activity

  2009cites this paper
• Bordetella pertussis Expresses a Functional Type III Secretion System That Subverts Protective Innate and Adaptive Immune Responses

  2008cites this paper
• Supplementation of whole-cell pertussis vaccines with lipopolysaccharide analogs: modification of vaccine-induced immune responses.

  2008cites this paper
• The Bordetella type III secretion system: its application to vaccine development

  2008cites this paper
• Immunodominance in Mouse and Human CD4+ T-Cell Responses Specific for the Bordetella pertussis Virulence Factor P.69 Pertactin

  2008cites this paper
• Lipopolysaccharide Analogs Improve Efficacy of Acellular Pertussis Vaccine and Reduce Type I Hypersensitivity in Mice

  2007cites this paper
• Consequences of the expression of lipopolysaccharide-modifying enzymes for the efficacy and reactogenicity of whole-cell pertussis vaccines.

  2007cites this paper
• Osmolarity affects Bvg-mediated virulence regulation by Bordetella pertussis.

  2007cites this paper
• Pertussis Toxin Targets Airway Macrophages To Promote Bordetella pertussis Infection of the Respiratory Tract

  2007cites this paper
• Improving pertussis vaccines by lipopolysaccharide engineering

  2007cites this paper
• Autoregulation Is Essential for Precise Temporal and Steady-State Regulation by the Bordetella BvgAS Phosphorelay

  2006cites this paper
• Species- and Strain-Specific Control of a Complex, Flexible Regulon by Bordetella BvgAS

  2006cites this paper
• Growth Phase- and Nutrient Limitation-Associated Transcript Abundance Regulation in Bordetella pertussis

  2006cites this paper
• Pertussis Toxin and Adenylate Cyclase Toxin Provide a One-Two Punch for Establishment of Bordetella pertussis Infection of the Respiratory Tract

  2005cites this paper
• Evaluation of the Role of the Bvg Intermediate Phase in Bordetella pertussis during Experimental Respiratory Infection

  2005cites this paper
• Suppression of Serum Antibody Responses by Pertussis Toxin after Respiratory Tract Colonization by Bordetella pertussis and Identification of an Immunodominant Lipoprotein

  2004cites this paper
• Strain-Dependent Role of BrkA during Bordetella pertussis Infection of the Murine Respiratory Tract

  2004cites this paper
• Efficacies of whole cell and acellular pertussis vaccines against Bordetella parapertussis in a mouse model.

  2004cites this paper
• Bordetella pertussis Acquires Resistance to Complement-Mediated Killing In Vivo

  2003cites this paper
• Analysis of bvgR Expression in Bordetella pertussis

  2003cites this paper
• Pertussis Toxin Plays an Early Role in Respiratory Tract Colonization by Bordetella pertussis

  2003cites this paper
• Comparative Phenotypic Analysis of the Bordetella parapertussis Isolate Chosen for Genomic Sequencing

  2002cites this paper
• Differential Regulation of Bvg-Activated Virulence Factors Plays a Role in Bordetella pertussisPathogenicity

  2001cites this paper
• Co-expression of the Bordetella pertussis leader peptidase I results in enhanced processing and expression of the pertussis toxin S1 subunit in Escherichia coli.

  2000cites this paper
• Pregenomic Comparative Analysis betweenBordetella bronchiseptica RB50 and Bordetella pertussis Tohama I in Murine Models of Respiratory Tract Infection

  1999cites this paper
• Analysis of BvgA Activation of the Pertactin Gene Promoter in Bordetella pertussis

  1999cites this paper
• Construction and characterisation of Salmonella typhimurium aroA simultaneously expressing the five pertussis toxin subunits.

  1998cites this paper
• Mutations Affecting the α Subunit ofBordetella pertussis RNA Polymerase Suppress Growth Inhibition Conferred by Short C-Terminal Deletions of the Response Regulator BvgA

  1998cites this paper
• Expression of a synthetic pertussis toxin operon in Escherichia coli.

  1997cites this paper
• Genomic fluidity of Bordetella pertussis assessed by a new method for chromosomal mapping

  1997cites this paper
• Antigenic switching and pathogenicity: environmental effects on virulence gene expression in Bordetella pertussis.

  1991cites this paper
• Genetic analysis of bacterial virulence determinants in Bordetella pertussis and the pathogenetic Yersinia.

  1985cites this paper
• Effect of Histamine‐Sensitizing Factor of Bordetella pertussis on Pharmacologic Response of Rat Atria

  1982cites this paper
• Japan's experience in pertussis epidemiology and vaccination in the past thirty years.

  1980cites this paper
• Antigenic structure and phase variation in Bordetella pertussis.

  1969cites this paper
• Studies on Haemophilus pertussis. X. On the significance of protective antibody in passive immunization.

  1958cites this paper